Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10496192rdf:typepubmed:Citationlld:pubmed
pubmed-article:10496192lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10496192lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:10496192lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:10496192lifeskim:mentionsumls-concept:C0026565lld:lifeskim
pubmed-article:10496192lifeskim:mentionsumls-concept:C2825032lld:lifeskim
pubmed-article:10496192lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:10496192lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:10496192lifeskim:mentionsumls-concept:C0026538lld:lifeskim
pubmed-article:10496192lifeskim:mentionsumls-concept:C0264716lld:lifeskim
pubmed-article:10496192lifeskim:mentionsumls-concept:C0453884lld:lifeskim
pubmed-article:10496192lifeskim:mentionsumls-concept:C0148345lld:lifeskim
pubmed-article:10496192pubmed:issue3lld:pubmed
pubmed-article:10496192pubmed:dateCreated1999-11-2lld:pubmed
pubmed-article:10496192pubmed:abstractTextThe use of inotropic agents in the therapy of patients with congestive heart failure (CHF) is controversial. One concern regarding inotropic therapy has been that drug withdrawal could be associated with a worsening of symptoms.lld:pubmed
pubmed-article:10496192pubmed:languageenglld:pubmed
pubmed-article:10496192pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10496192pubmed:citationSubsetIMlld:pubmed
pubmed-article:10496192pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10496192pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10496192pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10496192pubmed:statusMEDLINElld:pubmed
pubmed-article:10496192pubmed:monthSeplld:pubmed
pubmed-article:10496192pubmed:issn1071-9164lld:pubmed
pubmed-article:10496192pubmed:authorpubmed-author:YoungJ DJDlld:pubmed
pubmed-article:10496192pubmed:authorpubmed-author:CarsonPPlld:pubmed
pubmed-article:10496192pubmed:authorpubmed-author:FeldmanA MAMlld:pubmed
pubmed-article:10496192pubmed:authorpubmed-author:WhiteB GBGlld:pubmed
pubmed-article:10496192pubmed:authorpubmed-author:BourgeRRlld:pubmed
pubmed-article:10496192pubmed:authorpubmed-author:JaskiBBlld:pubmed
pubmed-article:10496192pubmed:authorpubmed-author:HolubkovRRlld:pubmed
pubmed-article:10496192pubmed:authorpubmed-author:LoftusSSlld:pubmed
pubmed-article:10496192pubmed:authorpubmed-author:SoranOOlld:pubmed
pubmed-article:10496192pubmed:issnTypePrintlld:pubmed
pubmed-article:10496192pubmed:volume5lld:pubmed
pubmed-article:10496192pubmed:ownerNLMlld:pubmed
pubmed-article:10496192pubmed:authorsCompleteYlld:pubmed
pubmed-article:10496192pubmed:pagination195-200; discussion 201-2lld:pubmed
pubmed-article:10496192pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10496192pubmed:meshHeadingpubmed-meshheading:10496192...lld:pubmed
pubmed-article:10496192pubmed:meshHeadingpubmed-meshheading:10496192...lld:pubmed
pubmed-article:10496192pubmed:meshHeadingpubmed-meshheading:10496192...lld:pubmed
pubmed-article:10496192pubmed:meshHeadingpubmed-meshheading:10496192...lld:pubmed
pubmed-article:10496192pubmed:meshHeadingpubmed-meshheading:10496192...lld:pubmed
pubmed-article:10496192pubmed:meshHeadingpubmed-meshheading:10496192...lld:pubmed
pubmed-article:10496192pubmed:meshHeadingpubmed-meshheading:10496192...lld:pubmed
pubmed-article:10496192pubmed:meshHeadingpubmed-meshheading:10496192...lld:pubmed
pubmed-article:10496192pubmed:meshHeadingpubmed-meshheading:10496192...lld:pubmed
pubmed-article:10496192pubmed:meshHeadingpubmed-meshheading:10496192...lld:pubmed
pubmed-article:10496192pubmed:meshHeadingpubmed-meshheading:10496192...lld:pubmed
pubmed-article:10496192pubmed:meshHeadingpubmed-meshheading:10496192...lld:pubmed
pubmed-article:10496192pubmed:meshHeadingpubmed-meshheading:10496192...lld:pubmed
pubmed-article:10496192pubmed:year1999lld:pubmed
pubmed-article:10496192pubmed:articleTitleEffect of inotrope withdrawal on morbidity and mortality in patients with chronic heart failure: results of the vesnarinone trial withdrawal substudy. Vest Withdrawal Substudy Group.lld:pubmed
pubmed-article:10496192pubmed:affiliationCardiovascular Institute of the University of Pittsburgh Medical Center Health System, Pennsylvania, USA.lld:pubmed
pubmed-article:10496192pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10496192pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10496192pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10496192pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:10496192pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:10496192pubmed:publicationTypeMulticenter Studylld:pubmed